Cargando…
Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965843/ https://www.ncbi.nlm.nih.gov/pubmed/33744352 http://dx.doi.org/10.1016/j.jaad.2021.03.038 |
_version_ | 1783665650262081536 |
---|---|
author | Speeckaert, Reinhart Lambert, Jo Puig, Lluís Speeckaert, Marijn Lapeere, Hilde De Schepper, Sofie van Geel, Nanja |
author_facet | Speeckaert, Reinhart Lambert, Jo Puig, Lluís Speeckaert, Marijn Lapeere, Hilde De Schepper, Sofie van Geel, Nanja |
author_sort | Speeckaert, Reinhart |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7965843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | by the American Academy of Dermatology, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79658432021-03-17 Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” Speeckaert, Reinhart Lambert, Jo Puig, Lluís Speeckaert, Marijn Lapeere, Hilde De Schepper, Sofie van Geel, Nanja J Am Acad Dermatol JAAD Online by the American Academy of Dermatology, Inc. 2021-08 2021-03-17 /pmc/articles/PMC7965843/ /pubmed/33744352 http://dx.doi.org/10.1016/j.jaad.2021.03.038 Text en © 2021 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | JAAD Online Speeckaert, Reinhart Lambert, Jo Puig, Lluís Speeckaert, Marijn Lapeere, Hilde De Schepper, Sofie van Geel, Nanja Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” |
title | Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” |
title_full | Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” |
title_fullStr | Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” |
title_full_unstemmed | Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” |
title_short | Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” |
title_sort | comment on “an evidence-based guide to sars-cov-2 vaccination of patients on immunotherapies in dermatology” |
topic | JAAD Online |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965843/ https://www.ncbi.nlm.nih.gov/pubmed/33744352 http://dx.doi.org/10.1016/j.jaad.2021.03.038 |
work_keys_str_mv | AT speeckaertreinhart commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology AT lambertjo commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology AT puiglluis commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology AT speeckaertmarijn commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology AT lapeerehilde commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology AT descheppersofie commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology AT vangeelnanja commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology |